Correction to: Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients Yu ShiXiao ChenChun Qiao Correction 24 June 2024
Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT Wenwen GuoHaixiao ZhangErlie Jiang Research 22 June 2024
Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study Leyu WangLiwei FangBing Han Research 22 June 2024
Correction to: Spanish registry of hemoglobinopathies and rare anemias (REHem- AR): demographics, complications, and management of patients with β-thalassemia Eduardo J. Bardón-CanchoJosé Manuel Marco-SánchezElena Cela Correction Open access 21 June 2024
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP Boris KubuschokBurkhard OtrembaTobias Foierl Research Open access 20 June 2024
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation Xuanqi CaoZheng LiXiaowen Tang Research Open access 20 June 2024
TGF-β: an active participant in the immune and metabolic microenvironment of multiple myeloma Han-Yue XueFang Wei Review Open access 20 June 2024
Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP Yingqiao ZhuYan WangChangcheng Zheng Research 19 June 2024
Myeloproliferative neoplasm with eosinophilia and coexisting BCR::ABL1 and PDGFRB rearrangement: favorable and rapid response to imatinib Sun YaoLiu NaHu Liangding Case Report 18 June 2024
Analysis of CCND3 mutations in diffuse large B-cell lymphoma Wei HuaYue LiWei Xu Research 18 June 2024
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE Keshu ZhouTingyu WangLugui Qiu Research Open access 18 June 2024
Clinicopathological analysis of immunohistochemical CD47 and signal-regulatory protein-α expression in Extranodal Natural killer/T-cell lymphoma Zaixiang TanQing ZhangWei Sang Research 18 June 2024
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens? E. U. SuárezB. Boludaon behalf of the PETHEMA group Research 17 June 2024
Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations Xue-zhu WangXue-min GaoXin-xin Cao Case Report 15 June 2024
Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia Maierbiya AbulimitiZheng-yi JiaJie Wang Research 15 June 2024
Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience Patrycja ZielińskaAgata Wieczorkiewicz-KabutGrzegorz Helbig Research Open access 15 June 2024
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report Valentina Maria ManieriMassimo OffidaniSonia Morè Case Report 14 June 2024
A HNRNPC::RARB variant of acute promyelocytic leukemia with concurrent myeloid sarcoma of the spine Ting LiPing WuHui Wang Correspondence 12 June 2024
Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib Daniele CattaneoNicole GalliAlessandra Iurlo Research 12 June 2024
Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study Zhengrui XiaoZhiqiang HeIrina Murakhovskaya Research Open access 12 June 2024
CD56bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation Xie JuanZeying FanXiangyu Zhao Research 11 June 2024
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study Alon RozentalErez HalperinAdi Shacham-Abulafia Research Open access 11 June 2024
Circulating subpopulations of non-cytotoxic ILCs in diffuse large B-cell lymphoma Agata ChwiedukA. SmagurS. Giebel Research Open access 11 June 2024
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials Songphol TungjitviboonkunNaharuthai BumrungratanayosSmuch Siramongkholkarn Review Open access 10 June 2024
High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China Zhiyu ZhangChunmei FuJinlan Pan Research 08 June 2024
Targeting histone deacetylase 1 (HDAC1) in the bone marrow stromal cells revers imatinib resistance by modulating IL-6 in Ph + acute lymphoblastic leukemia Danna WeiXiaoling LiangJingrong Zhang Research 07 June 2024
Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting Taku KikuchiNobuhiro TsukadaTadao Ishida Correspondence 06 June 2024
Association of routine hematological parameters with the development of monoclonal gammopathies: a case-control study of 134,740 patients Jakob Røllum-LarsenAnna Elise EngellHenrik Løvendahl Jørgensen Research Open access 06 June 2024
Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial Heng MeiXiaofan LiuYu Hu Research Open access 06 June 2024
Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid leukemia cells to chemotherapy Anthi BouchlaChristina D. SotiropoulouVasiliki Pappa Research Open access 06 June 2024
Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients Shuang WuJie ZhangTingxun Lu Original Article 06 June 2024
Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities Betül BudakEzgi Yağmur TükelYağmur Kiraz Research Open access 05 June 2024
Lymphocyte profile in peripheral blood of patients with multiple myeloma Tereza DekojováHana GmucováMonika Holubová Research 04 June 2024
Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p Boyang ZhengYueqi GengAichun Liu Research 03 June 2024
Reduced intensity conditioning regimen of fludarabine, busulfan, ATG based haploidentical stem cell transplantation for older or unfit patients Mingyue PanYibo WuYi Luo Research 03 June 2024
Effective management of heparin-resistant thrombosis: a case study on rivaroxaban therapy guided by thromboelastography Chuandong HouBing ZhaiXueChun Lu Letter to the Editor 01 June 2024
Immunophenotypic classification regarding prognosis in peripheral T cell lymphoma, NOS, and nodal T follicular helper T cell lymphoma, angioimmunoblastic-type Soyeon ChoiJae-Cheol JoHee Jeong Cha Research 30 May 2024
Chemotherapy vs. “TKI + immunotherapy” in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene Yan LiQin ZhangHaigang Shao Correspondence 29 May 2024
BeEAM vs. BEAM: evaluating conditioning regimens for autologous stem cell transplantation in patients with relapsed or refractory DLBCL Ruiqi WangXinghe ShangguanWenlong Zhang Research 29 May 2024
Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients Peipei YeMengjie WuYing Lu Research 29 May 2024
Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases Qingwei WangYixin HuShaoyan Hu Case Report Open access 28 May 2024
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience Giuseppe MeleDaniele DerudasDomenico Pastore Research 28 May 2024
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China Wei WangWei ZhangDao-bin Zhou Original Article 28 May 2024
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL) Adam BraunSalman OtoukeshIbrahim Aldoss Case Report Open access 24 May 2024
Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy Francesca Romana IoveneEnrico SantinelliLuigi Rigacci Case Report 23 May 2024
Flow-cytometry Assessment of DNA content and Immunophenotyping of Immune-cells in Lymph-node-specimens as a Potential Diagnostic Signature of Aggressiveness in B-Non-Hodgkin Lymphomas David AzoulayTal TapuchiNetanel A. Horowitz Research Open access 23 May 2024
A preliminary study of roxadustat in the treatment of aplastic anemia patients with inadequate erythroid responses Yimeng ShiYufei ZhaoFengkui Zhang Research Open access 22 May 2024
Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomes Francesca PalandriF. BranzantiM. Cavo Research Open access 21 May 2024
The effectiveness of the doxorubicin-etoposide-methylprednisolone regimen for adult HLH secondary to rheumatic disease Dongfei YinJingshi WangZhao Wang Research 21 May 2024